Andreas Goutopoulos, Actithera CEO
July 9, 2025 03:00 AM EDTUpdated 06:20 AM
Financing
Startups
Manufacturing

Nim­ble ra­dio­phar­ma biotech Ac­tithera gets $75M to en­ter the clin­ic

Kyle LaHucik

Biotech Correspondent

For a year and a half, Ac­tithera was es­sen­tial­ly a one-man show.

As the ra­dio­phar­ma start­up’s on­ly em­ploy­ee, CEO An­dreas Goutopou­los had to hus­tle for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Mer­ck drops $10B for res­pi­ra­to­ry drug­mak­er Verona Phar­ma in its first ac­qui­si­tion of 2025

Who pays the most in bio­phar­ma? We an­a­lyzed me­di­an pay at 177 com­pa­nies

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

As­traZeneca’s Alex­ion inks AAV cap­sid deal with JCR Phar­ma

FDA ap­proves new dos­ing of Lil­ly’s Alzheimer’s drug to low­er brain swelling risks

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times